Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022)
Prothena Corp Public (PRTA) recorded quarterly Other Non-Current Liabilities of $553000.0 in Q4 2022, little changed quarter-over-quarter from $553000.0 in Q3 2022, and little changed on a YoY basis from $553000.0 in Q4 2021.
Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022) Analysis & Trends
Prothena Corp Public's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $553000.0 for Q4 2022.
- In Q4 2022, Other Non-Current Liabilities changed 0.0% year-over-year to $553000.0; the TTM figure through Dec 2022 stood at $553000.0 (changed 0.0% YoY), while the FY2022 annual figure was $553000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities was $553000.0 for Q4 2022 at Prothena Corp Public, roughly flat from $553000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $553000.0 in Q3 2018 to a low of $553000.0 in Q3 2018.
- Historically, Other Non-Current Liabilities has averaged $553000.0 across 5 years, with a median of $553000.0 in 2018.
- Biggest YoY gain for Other Non-Current Liabilities was 0.0% in 2019; the steepest drop was 0.0% in 2019.
- A 5-year view of Other Non-Current Liabilities shows it stood at $553000.0 in 2018, then changed by 0.0% to $553000.0 in 2019, then changed by 0.0% to $553000.0 in 2020, then changed by 0.0% to $553000.0 in 2021, then changed by 0.0% to $553000.0 in 2022.
- The last three Other Non-Current Liabilities figures came in at $553000.0 (Q4 2022), $553000.0 (Q3 2022), and $553000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 553,000.00 |
| Sep 30, 2022 | 553,000.00 |
| Jun 30, 2022 | 553,000.00 |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 553,000.00 |
| Sep 30, 2021 | 553,000.00 |
| Jun 30, 2021 | 553,000.00 |
| Mar 31, 2021 | 553,000.00 |
| Dec 31, 2020 | 553,000.00 |
| Sep 30, 2020 | 553,000.00 |
| Jun 30, 2020 | 553,000.00 |
| Mar 31, 2020 | 553,000.00 |
| Dec 31, 2019 | 553,000.00 |
| Sep 30, 2019 | 553,000.00 |
| Jun 30, 2019 | 553,000.00 |
| Mar 31, 2019 | 553,000.00 |
| Dec 31, 2018 | 553,000.00 |
| Sep 30, 2018 | 553,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Sep 30, 2016 | 98,000.00 |